With a track record of exceeding recruitment targets and upholding the highest quality standards, Anima Research partners with top-tier pharmaceutical companies to deliver innovative and reliable trial solutions across various therapeutic areas, including women’s health, sleep disorders, heart and lung diseases, skin conditions, and mental disorders. This partnership represents a significant milestone in Anima Research's growth, supporting its expansion across Europe and beyond.
The Quinz deal team consisted of Bart Lintermans and Matteo De Grauwe. Quinz’s life sciences team led by Olivier Van Obberghen supported the transaction on regulatory and consortia matters.
